Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis

Phase 1

• Conditions: Osteoporosis

• Registration Number: NCT00154609
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

We, the investigators at National Taiwan University Hospital, have determined the therapeutic and toxic effects of the traditional herb on the ovariectomized Wistar rat.

The final years will determine its effects on the therapy of women who are over 45 years old and postmenopausal with osteoporosis.

Detailed Description

Research of this traditional chinese clinical medicine, Gusuibu, curative effect is planned for three years time. The entire study aims to evaluate the effect of the traditional chinese medicine on postmenopausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal women with established osteoporosis.

Study Timeline

• Status Verified: 2002-01
• Study Start: 2002-01
• Study First Submitted: 2005-09-09
• Study First Submitted QC: 2005-09-09
• Study First Posted: 2005-09-12
• Last Update Submitted: 2006-01-20
• Last Update Posted: 2006-01-23

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• Postmenopausal osteoporosis

Exclusion Criteria

• Insulin dependent diabetes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
The project is aimed to investigate the clinical effects of the water extract of Gu-Sui-Bu from the aspects of animal and clinic studies.

Trial Locations

Locations (1)

National Taiwan University Medical Center; 🇨🇳 Taipei, 7, Chung-Shan South Road, Taiwan